104 related articles for article (PubMed ID: 38837565)
1. Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia.
Alqahtani S; Ramakrishnan R; E S; Wang SA; Nunez C; McCall D; Garcia MB; Roth ME; Cuglievan B; Gibson A
Pediatr Blood Cancer; 2024 Jun; ():e31123. PubMed ID: 38837565
[No Abstract] [Full Text] [Related]
2. Short-course Venetoclax With Standard Chemotherapy Is Effective in Early T-cell Precursor Acute Lymphoblastic Leukemia.
Borah P; Dayal N; Pathak S; Naithani R
J Pediatr Hematol Oncol; 2023 Jul; 45(5):271-274. PubMed ID: 37027330
[TBL] [Abstract][Full Text] [Related]
3. Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.
Ratnaparkhe M; Hlevnjak M; Kolb T; Jauch A; Maass KK; Devens F; Rode A; Hovestadt V; Korshunov A; Pastorczak A; Mlynarski W; Sungalee S; Korbel J; Hoell J; Fischer U; Milde T; Kramm C; Nathrath M; Chrzanowska K; Tausch E; Takagi M; Taga T; Constantini S; Loeffen J; Meijerink J; Zielen S; Gohring G; Schlegelberger B; Maass E; Siebert R; Kunz J; Kulozik AE; Worst B; Jones DT; Pfister SM; Zapatka M; Lichter P; Ernst A
Leukemia; 2017 Oct; 31(10):2048-2056. PubMed ID: 28196983
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy and safety of venetoclax combined with multidrug chemotherapy in the treatment of 15 patients with relapsed or refractory early T-cell precursor acute lymphoblastic leukemia].
Kong JY; Zong LH; Pu Y; Liu Y; Kong X; Li MY; Zhang J; Song BQ; Xue SL; Tang XW; Qiu HY; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):649-653. PubMed ID: 37803838
[No Abstract] [Full Text] [Related]
5. Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review.
Zhao Y; Jiang S; Tang Y; Zhao L
Int J Hematol; 2023 Oct; 118(4):483-488. PubMed ID: 37269505
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Diagnosis of Ataxia-Telangiectasia in an Adolescent Patient With a Remote History of T-Cell Leukemia.
Sze SK; Lederman HM; Crawford TO; Wangler MF; Lewis AM; Kastan MB; Dibra HK; Taylor AMR; Wechsler DS
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e138-e140. PubMed ID: 31743320
[TBL] [Abstract][Full Text] [Related]
7. Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Gibson A; Trabal A; McCall D; Khazal S; Toepfer L; Bell DH; Roth M; Mahadeo KM; Nunez C; Short NJ; DiNardo C; Konopleva M; Issa GC; Ravandi F; Jain N; Borthakur G; Kantarjian HM; Jabbour E; Cuglievan B
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008312
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute leukemia in children with ataxia telangiectasia (A-T).
Schoenaker MH; Suarez F; Szczepanski T; Mahlaoui N; Loeffen JL
Eur J Med Genet; 2016 Dec; 59(12):641-646. PubMed ID: 27238889
[TBL] [Abstract][Full Text] [Related]
9. Complicated but successful treatment of a patient with ataxia telangiectasia and pre-B-acute lymphoblastic leukemia.
Brummel B; Bernbeck B; Schneider DT
Klin Padiatr; 2010 Nov; 222(6):391-4. PubMed ID: 21058227
[TBL] [Abstract][Full Text] [Related]
10. Clinical Experience With Venetoclax Combined With Chemotherapy for Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia.
Richard-Carpentier G; Jabbour E; Short NJ; Rausch CR; Savoy JM; Bose P; Yilmaz M; Jain N; Borthakur G; Ohanian M; Alvarado Y; Rytting M; Kebriaei P; Konopleva M; Kantarjian H; Ravandi F
Clin Lymphoma Myeloma Leuk; 2020 Apr; 20(4):212-218. PubMed ID: 32035785
[TBL] [Abstract][Full Text] [Related]
11. Case report: Treatment of two cases of recurrent/refractory early T-cell precursor acute lymphoblastic leukemia with venetoclax combined with the CAG regimen.
Jiang Y; Ji L; Jin X; Wu H; He M; Shen F; Xu X; Jiang H
Front Med (Lausanne); 2024; 11():1358161. PubMed ID: 38523911
[TBL] [Abstract][Full Text] [Related]
12. New diagnosis of atypical ataxia-telangiectasia in a 17-year-old boy with T-cell acute lymphoblastic leukemia and a novel ATM mutation.
Roohi J; Crowe J; Loredan D; Anyane-Yeboa K; Mansukhani MM; Omesi L; Levine J; Revah Politi A; Zha S
J Hum Genet; 2017 Apr; 62(5):581-584. PubMed ID: 28123174
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T-cell acute lymphoblastic leukemia harboring a cryptic ETV6-NTRK3 fusion.
Zhou K; Gong D; He C; Xiao M; Zhang M; Huang W
Mol Carcinog; 2023 Jul; 62(7):899-906. PubMed ID: 37036164
[TBL] [Abstract][Full Text] [Related]
14. Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Pullarkat VA; Lacayo NJ; Jabbour E; Rubnitz JE; Bajel A; Laetsch TW; Leonard J; Colace SI; Khaw SL; Fleming SA; Mattison RJ; Norris R; Opferman JT; Roberts KG; Zhao Y; Qu C; Badawi M; Schmidt M; Tong B; Pesko JC; Sun Y; Ross JA; Vishwamitra D; Rosenwinkel L; Kim SY; Jacobson A; Mullighan CG; Alexander TB; Stock W
Cancer Discov; 2021 Jun; 11(6):1440-1453. PubMed ID: 33593877
[TBL] [Abstract][Full Text] [Related]
15. Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies.
Zhai Y; Tang Q; Fang DD; Deng J; Zhang K; Wang Q; Yin Y; Fu C; Xue SL; Li N; Zhou F; Yang D
Clin Cancer Res; 2023 Jan; 29(1):183-196. PubMed ID: 36240005
[TBL] [Abstract][Full Text] [Related]
16. Novel biallelic ATM mutations coexist with a mosaic form of triple X syndrome in an 11-year-old girl at remission after T cell acute leukemia.
Sharapova SO; Valochnik AV; Guryanova IE; Sakovich IS; Aleinikova OV
Immunogenetics; 2018 Sep; 70(9):613-617. PubMed ID: 29492593
[TBL] [Abstract][Full Text] [Related]
17. Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.
Ehrlich LA; Yang-Iott K; Bassing CH
Cell Cycle; 2014; 13(19):3076-82. PubMed ID: 25486566
[TBL] [Abstract][Full Text] [Related]
18. Ataxia telangiectasia associated with B-cell lymphoma: the effect of a half-dose of the drugs administered according to the acute lymphoblastic leukemia standard risk protocol.
Yamada Y; Inoue R; Fukao T; Kaneko H; Isogai K; Fukuda S; Shimozawa N; Suzuki Y; Kondo N; Azuma E; Sakurai M
Pediatr Hematol Oncol; 1998; 15(5):425-9. PubMed ID: 9783309
[TBL] [Abstract][Full Text] [Related]
19. Acute lymphoblastic leukemia in early childhood as the presenting sign of ataxia-telangiectasia variant.
Bielorai B; Fisher T; Waldman D; Lerenthal Y; Nissenkorn A; Tohami T; Marek D; Amariglio N; Toren A
Pediatr Hematol Oncol; 2013 Sep; 30(6):574-82. PubMed ID: 23509889
[TBL] [Abstract][Full Text] [Related]
20. Ataxia telangiectasia and acute lymphoblastic leukemia: report of a case.
Pastore G; Cordero di Montezemolo L; Madon E
Tumori; 1981 Dec; 67(6):585-7. PubMed ID: 6950588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
